Recent findings from peer-reviewed publications and clinical registries, explained in plain language. Each finding includes its evidence stage and a link to the original source.
Understanding evidence levels▼
PreclinicalLab or cell studies — no human data yet.
Animal StudyResults in animals only — may not apply to humans.
Phase 1 TrialFirst-in-human safety testing in small groups.
Phase 2 TrialEarly effectiveness testing in a larger group.
Phase 3 TrialLarge controlled trial — the strongest trial evidence.
Observational StudyPatterns observed in populations — not a controlled trial.
ReviewSummary analysis of multiple existing studies.
Meta-AnalysisStatistical pooling of results from multiple studies.
Observational StudyPatterns observed in populations over time, not a controlled experiment.Lung CancerPublished: April 3, 2026
Barriers to Lung Cancer Screening in Black Adults in NYC
Researchers interviewed Black adults in New York City to understand why they don't get lung cancer screenings. They found that lack of knowledge, mistrust of healthcare, and limited access to screening services are major barriers. More research is needed to develop effective solutions.
Why it matters: This study highlights the need for culturally tailored interventions to promote lung cancer screening among Black adults.
Lab StudyLaboratory experiments on cells or tissue. No human or animal data.Colorectal CancerPublished: April 3, 2026
UXT protein linked to colorectal cancer progression
Researchers studied the role of UXT protein in colorectal cancer. They found that UXT is associated with higher levels of a chemical called putrescine, which may contribute to cancer growth. Lab experiments showed that reducing UXT levels slowed cancer cell growth.
Why it matters: This finding may help scientists understand how colorectal cancer progresses and identify new targets for treatment.
The study was conducted in lab experiments and has not been tested in humans.
Lab StudyLaboratory experiments on cells or tissue. No human or animal data.Lung CancerPublished: April 3, 2026
Genetic link to lung cancer risk found in new study
Researchers used a genetic approach to investigate the link between a protein called hepatocyte growth factor and lung cancer. They found that people with higher levels of this protein were more likely to develop lung cancer, especially a type called lung adenocarcinoma. However, more research is needed to confirm these findings.
Why it matters: This study provides new insights into the potential causes of lung cancer, which could help scientists develop more effective prevention and treatment strategies.
Lab StudyLaboratory experiments on cells or tissue. No human or animal data.Lung CancerPublished: April 3, 2026
New Strategy to Improve Lung Cancer Treatment
Researchers studied how a protein called HIF-1α affects lung cancer treatment. They found that targeting this protein can make a common lung cancer drug more effective. This approach may help overcome a common problem with lung cancer treatment.
Why it matters: This finding could lead to new ways to improve lung cancer treatment and help patients with this disease.
Efficacy
Combined treatment with HIF-1α siRNA and erlotinib synergistically suppressed cell proliferation, induced apoptosis, and inhibited invasion more effectively than single-agent treatments.
This study was conducted in lab experiments using cell lines.
Lab StudyLaboratory experiments on cells or tissue. No human or animal data.Lung CancerPublished: April 3, 2026
New Blood Test for Lung Cancer Shows Promise
Researchers used a special blood test to look for differences in proteins between people with lung cancer and those with harmless lung nodules. They found some differences, but more research is needed to confirm these findings. This early study suggests that blood tests might be useful for detecting lung cancer earlier.
Why it matters: This finding could lead to better ways to diagnose and manage lung cancer, especially in people who are at high risk.
The study was small and needs to be repeated with a larger group of people.
Observational StudyPatterns observed in populations over time, not a controlled experiment.Colorectal CancerPublished: April 3, 2026
Cancer Mortality Trends in Young Adults Projected Through 2026
Researchers analyzed cancer deaths in 15 upper-middle and high-income countries to project mortality trends among young adults aged 25-49. They found that overall cancer mortality is expected to decline by 2026, but colorectal cancer mortality may increase in some countries.
Why it matters: This study provides insight into cancer mortality trends among young adults, which can inform future research and public health strategies.
Observational StudyPatterns observed in populations over time, not a controlled experiment.Breast CancerPublished: April 3, 2026
MRI Scans May Help Predict Cancer Treatment Success
Researchers studied how MRI scans before and after cancer treatment could help predict whether patients with invasive ductal carcinoma would have no cancer left after treatment. They found some associations between MRI scan results and treatment success, but more research is needed to confirm these findings.
Why it matters: Understanding how to use MRI scans to predict treatment success could help doctors make more informed decisions about patient care.
This study had a small sample size of 28 patients and requires further validation in larger studies.
✦ Significant findingA meaningful signal from later-stage research, or a strong phase 2 result that stands out from routine findings.Phase 3 TrialLarge controlled trial comparing treatments. The strongest level of trial evidence.Lung CancerPublished: April 3, 2026
Mindfulness Helps Lung Cancer Patients Manage Fatigue and Emotions
Researchers studied whether mindfulness-based stress reduction can help lung cancer patients feel less tired, anxious, and depressed. They found that patients who practiced mindfulness for 8 weeks reported improvements in these areas. However, it's unclear how long these benefits last.
Why it matters: This finding could lead to new ways to support lung cancer patients during and after treatment.
Efficacy
Fatigue levels in the MBSR group peaked at the fourth week but returned close to baseline levels by 3 months post-intervention, while the Control group maintained elevated fatigue scores (P < .05).
Observational StudyPatterns observed in populations over time, not a controlled experiment.Breast CancerPublished: April 3, 2026
No Link Found Between Statins and Postmenopausal Breast Cancer Risk
Researchers studied 35,315 postmenopausal women in Sweden to see if taking statins affected their risk of getting breast cancer. They found no significant link between statin use and breast cancer risk over eight years. The study's results are consistent with previous research.
Why it matters: This finding is important for understanding the relationship between statin use and breast cancer risk, which could inform future research and public health guidelines.
Observational StudyPatterns observed in populations over time, not a controlled experiment.Breast CancerPublished: April 3, 2026
Endocrine TherapyTreatments that reduce or block hormones that fuel certain cancers.Click for full explanation → Adherence Varies Across Data Sources
Researchers compared how well breast cancer patients took their medication using two different types of data: electronic health records and insurance claims. They found that these two data sources sometimes gave different answers about how well patients were taking their medication. The researchers also found that language and insurance status might affect how well patients took their medication.
Why it matters: This finding could help researchers better understand how to measure medication adherence in diverse populations.
Lab StudyLaboratory experiments on cells or tissue. No human or animal data.Lung CancerPublished: April 3, 2026
Gene Linked to Lung Cancer Progression
Researchers used a statistical method called Mendelian randomization to identify a gene called STMN1 that may contribute to lung cancer progression. They found that high levels of STMN1 were associated with a shorter survival and a less effective immune response in lung cancer patients. The study suggests that STMN1 may play a role in the development of lung cancer, but more research is needed to confirm this.
Why it matters: This finding could lead to new targets for lung cancer therapy and a better understanding of how the disease progresses.
The study was conducted in a lab setting and more research is needed to confirm the findings in humans.
Lab StudyLaboratory experiments on cells or tissue. No human or animal data.Pancreatic CancerPublished: April 3, 2026
Researchers Identify Key Players in Pancreatic Cancer's Immune Evasion
Scientists studied pancreatic cancer's tumor environment and found that a protein called PAI1 helps cancer cells evade the immune system. They also discovered that another protein, tPA, has a role in fighting cancer. The researchers found that when they removed PAI1, the cancer grew faster, and when they removed tPA, the immune system's ability to fight cancer worsened.
Why it matters: This finding could help researchers develop new treatments to overcome pancreatic cancer's ability to evade the immune system.
This study was conducted in a lab setting and may not directly translate to human patients.
